Literature DB >> 9707560

The Candida albicans KRE9 gene is required for cell wall beta-1, 6-glucan synthesis and is essential for growth on glucose.

M Lussier1, A M Sdicu, S Shahinian, H Bussey.   

Abstract

We have isolated CaKRE9, a gene from Candida albicans, that is a functional homologue of the Saccharomyces cerevisiae KRE9 gene involved in beta-1,6-glucan synthesis. Disruption of the CaKRE9 gene in C. albicans shows that CaKre9p is required for the synthesis or assembly of this fungal polymer. Homozygous null disruptants of CaKRE9 grow poorly on galactose and fail to form hyphae in serum, and, in growth medium containing glucose, the gene is essential. Thus, the CaKRE9 gene product is a potentially useful candidate as a target for fungal-specific drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707560      PMCID: PMC21421          DOI: 10.1073/pnas.95.17.9825

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Architecture of the yeast cell wall. Beta(1-->6)-glucan interconnects mannoprotein, beta(1-->)3-glucan, and chitin.

Authors:  R Kollár; B B Reinhold; E Petráková; H J Yeh; G Ashwell; J Drgonová; J C Kapteyn; F M Klis; E Cabib
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

3.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.

Authors:  D Sanglard; F Ischer; M Monod; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 4.  Review: cell wall assembly in yeast.

Authors:  F M Klis
Journal:  Yeast       Date:  1994-07       Impact factor: 3.239

5.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function.

Authors:  T Mio; T Yamada-Okabe; T Yabe; T Nakajima; M Arisawa; H Yamada-Okabe
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

Review 7.  Life with 6000 genes.

Authors:  A Goffeau; B G Barrell; H Bussey; R W Davis; B Dujon; H Feldmann; F Galibert; J D Hoheisel; C Jacq; M Johnston; E J Louis; H W Mewes; Y Murakami; P Philippsen; H Tettelin; S G Oliver
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

8.  Isolation from Candida albicans of a functional homolog of the Saccharomyces cerevisiae KRE1 gene, which is involved in cell wall beta-glucan synthesis.

Authors:  C Boone; A Sdicu; M Laroche; H Bussey
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

9.  The yeast KRE9 gene encodes an O glycoprotein involved in cell surface beta-glucan assembly.

Authors:  J L Brown; H Bussey
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

10.  Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure.

Authors:  R D Gietz; R H Schiestl; A R Willems; R A Woods
Journal:  Yeast       Date:  1995-04-15       Impact factor: 3.239

View more
  16 in total

1.  Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation.

Authors:  Elisabetta Spreghini; Dana A Davis; Ryan Subaran; Michelle Kim; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2003-08

Review 2.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

3.  KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties.

Authors:  Ana B Herrero; Paula Magnelli; Michael K Mansour; Stuart M Levitz; Howard Bussey; Claudia Abeijon
Journal:  Eukaryot Cell       Date:  2004-12

4.  Comparative pathogenicity of different Actinobacillus suis O/K serotypes.

Authors:  D Slavić; J DeLay; M A Hayes; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

5.  The Golgi GDPase of the fungal pathogen Candida albicans affects morphogenesis, glycosylation, and cell wall properties.

Authors:  Ana B Herrero; Daniela Uccelletti; Carlos B Hirschberg; Angel Dominguez; Claudia Abeijon
Journal:  Eukaryot Cell       Date:  2002-06

6.  Large-scale identification of putative exported proteins in Candida albicans by genetic selection.

Authors:  L Monteoliva; M López Matas; C Gil; C Nombela; J Pla
Journal:  Eukaryot Cell       Date:  2002-08

7.  A Saccharomyces cerevisiae genome-wide mutant screen for altered sensitivity to K1 killer toxin.

Authors:  Nicolas Pagé; Manon Gérard-Vincent; Patrice Ménard; Maude Beaulieu; Masayuki Azuma; Gerrit J P Dijkgraaf; Huijuan Li; José Marcoux; Thuy Nguyen; Tim Dowse; Anne-Marie Sdicu; Howard Bussey
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

8.  Cell wall beta-(1,6)-glucan of Saccharomyces cerevisiae: structural characterization and in situ synthesis.

Authors:  Vishukumar Aimanianda; Cécile Clavaud; Catherine Simenel; Thierry Fontaine; Muriel Delepierre; Jean-Paul Latgé
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

9.  Isolation of Candida glabrata homologs of the Saccharomyces cerevisiae KRE9 and KNH1 genes and their involvement in cell wall beta-1,6-glucan synthesis.

Authors:  S Nagahashi; M Lussier; H Bussey
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

10.  Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis.

Authors:  Akihiro Kitamura; Kazuhiko Someya; Masato Hata; Ryohei Nakajima; Makoto Takemura
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.